Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,276 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

NCT07564401

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +8 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • Novartis Investigative Site Singapore
View Trial Details
Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

NCT07227298

Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • Providence Medical Foundation Fullerton, California, United States
View all 87 locations
View Trial Details
Recruiting

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

NCT06772623

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Phoenix /ID# 272971 Phoenix, Arizona, United States
  • Providence - St. Jude Medical Center /ID# 271414 Fullerton, California, United States
  • FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450 Oxnard, California, United States
  • UCLA - Santa Monica /ID# 271690 Santa Monica, California, United States
View all 121 locations
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

NCT06646276

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Local Institution - 0283 Hot Springs, Arkansas, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
View all 183 locations
View Trial Details
Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

NCT06303505

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +22 more
Locations
  • The University of Alabama Birmingham, Alabama, United States
  • Mount Sinai New York, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 29 locations
View Trial Details
Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

NCT07388524

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • Medical Oncology Hematology Consultants PA Newark, Delaware, United States
  • Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho, United States
  • Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho, United States
View all 63 locations
View Trial Details
Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT07155174

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Yale University School of Medicine /ID# 278181 New Haven, Connecticut, United States
  • Ocala Oncology Center /ID# 278269 Ocala, Florida, United States
  • Moffitt Cancer Center /ID# 277573 Tampa, Florida, United States
  • Fort Wayne Medical Oncology And Hematology /ID# 277336 Fort Wayne, Indiana, United States
View all 67 locations
View Trial Details
Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

NCT04410796

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UC Davis Cancer Center (Data Collection Only) Sacramento, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • John Hopkins Medical Center Baltimore, Maryland, United States
View all 18 locations
View Trial Details

Related conditions